The Evolving Role of Rapid-Acting Agents for the Treatment of MDD - a podcast by ReachMD

CME credits: 0.25

Valid until: 29-12-2022

Claim your CME credit at https://reachmd.com/programs/cme/the-evolving-role-of-rapid-acting-agents-for-the-treatment-of-mdd/13090/

Depression can cause a multitude of symptoms, many of which are associated with impairment that, if not treated appropriately, can go on for months or even years. With traditional antidepressants having a longer time to onset, the role of rapid-acting agents can greatly improve the quality of life for patients with major depressive disorder (MDD). Dr. Michael Thase and Dr. Sagar Parikh discuss the clinical diagnosis of MDD and the role of emerging neuroactive steroids. Tune in and fasten your seat belt for faster results!

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD